UNSPSC 51282518: Cefmepidium

This classification denotes a cephalosporin antibiotic with the molecular formula C23H25N6O8S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XLC35939WJ, chemically known as 4-((((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)thio)-1-methylpyridinium 72-(z)-(o-(1-carboxy-1-methylethyl)oxime) s-oxide. but generally known as cefmepidium, which bears US NIH Compound Identifier 9589472.

UNSPSC 51282518 Cefmepidium is a Commodity code, but the recent state and local opportunities tagged under it do not reflect pharmaceutical procurement aligned with the code's nominal scope. Instead, the tagged solicitations show state and local health agencies and municipalities procuring emergency response supplies, drug deactivation systems, direct-to-manufacturer pharmacy programs, generic multi-source pharmaceuticals distributed through wholesalers, and first-aid supplies for fire departments — a range of health-supply and pharmacy-benefit activities that diverge significantly from a single active pharmaceutical ingredient designation. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and multistate cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance), each seeking different categories of medical or pharmaceutical products through distinct procurement mechanisms.

Geographic activity spans Florida, Texas, Minnesota, and Oregon (through cooperative purchasing participation). Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first-aid supplies to the Fire Department Rescue Division, estimated at $700,000, designated as a small local business enterprise set-aside with a 5 percent bid discount; the Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit managers; and the Minnesota Department of Administration's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, effective July 1, 2026. The code shows little relevant recent activity; the mismatch between the code's nominal pharmaceutical-ingredient scope and the emergency-response and supply-chain procurement actually present suggests potential code-tagging inconsistency rather than active pursuit opportunity under this specific commodity designation.